Foam Dressing
Reference: TPS18
Type: Top Proven Switch Start Date: 1 November 2019
Expiry Date: While stock lasts
Type: Top Proven Switch Start Date: 1 November 2019
Expiry Date: While stock lasts
- Primary NPC – All varieties
- Comparable NPC – ELA362, ELA361, ELA359
- Price difference – Average 26%
- Trusts already purchasing – 77
- Contract – Advanced Wound Care
Foam dressings were a key focus area, accounting for 43% of our usage, so we began to look at standardising our product range to reduce variation and improve clinical practices. To support the review process, we decided to complete a snapshot audit of clinical practice across the hospital, which enabled us to quickly measure baseline wound care data and therefore assess the impact of change. We evaluated all available dressings and selected the most suitable product. Not only has the change to Allevyn positively impacted usage levels and increased our savings, the training and support provided by the Smith & Nephew ensured a smooth transition; allowing us to maintain a high quality of patient care throughout.Clare Wesley, Clinical Lead Nurse Tissue Viability
Shrewsbury and Telford Hospital NHS Trust
‘Proven Switch’ definition: based on an alternative already adopted by some NHS Supply Chain customer(s), which offer the largest potential savings nationally (i.e. across all of NHS Supply Chain’s customers). Identified based on the purchase history of customers, where the sales have stopped on the primary product and then started on the identified alternative product. Forecasted savings have been calculated based on the band 1 price of the primary product (i.e. the products currently used by trusts) minus the band 1 price of the alternative product multiplied by the last 12 months actual quantity purchased where a switch has been detected (switch: where sales have stopped on the primary product and then started on the identified alternative product). Potential savings have been calculated based on the band 1 price of the primary product (i.e. the products currently used by trusts) minus the band 1 price of the alternative product multiplied by the last 12 months actual quantity purchased. ‘No of trusts purchasing comparable products’ refers to NHS Supply Chain customers who already purchase the alternative product, this does not reflect the number of trusts who have made the switch from the primary to the alternative product. Trusts should check with clinical teams that the alternative product is suitable for its dedicated use in each instance. All savings and prices correct at time of publication. Read More / Read Less… »